Aadi Bioscience, Inc. (NASDAQ: AADI) reported Q2 EPS of ($0.87), $0.12 worse than the analyst estimate of ($0.75). Revenue for the quarter came in at $3.4 million versus the consensus estimate of $2.75 million.

For earnings history and earnings-related data on Aadi Bioscience, Inc. (AADI) click here.